Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Halberd Corp (OP: HALB ) 0.0064 UNCHANGED Streaming Delayed Price Updated: 3:43 PM EDT, Aug 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Halberd Corp < Previous 1 2 3 4 5 Next > Halberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process June 21, 2021 JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC PINK:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens June 16, 2021 Enables Extracorporeal Eradication of Pathogens from Cerebral Spinal Fluid Via Radio Frequency and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / June 16, 2021 / Halberd Corporation (OTC... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease June 09, 2021 JACKSON CENTER, PA / ACCESSWIRE / June 9, 2021 / Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer's Disease. By eliminating... From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Halberd Corporation Creates Two New and Stronger SARS-CoV-2 Neutralizing Antibodies June 07, 2021 Demonstrates Greater Binding Affinity Than Previous Antibodies JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful creation of two new... From Halberd Corporation Via AccessWire Topics Animal Testing Intellectual Property Regulatory Compliance Exposures Animal Testing COVID-19 Intellectual Property Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects June 01, 2021 JACKSON CENTER, PA / ACCESSWIRE / June 1, 2021 / Halberd Corporation (OTC PINK:HALB) announced the filing of a U. S. joint provisional patent application titled, "Antibody Conjugated Nanoparticle Assay... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody May 25, 2021 Breakthrough Achievement Enables Extracorporeal Eradication of Pathogens Via Radio Frequency Waves and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / May 25, 2021 / Halberd Corporation (OTC... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal "MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19 May 19, 2021 JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody May 17, 2021 JACKSON CENTER, PA / ACCESSWIRE / May 17, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated iron nanoparticles with Halberd's patent-pending monoclonal... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease May 13, 2021 JACKSON CENTER, PA / ACCESSWIRE / May 13, 2021 / Halberd Corporation (OTC PINK:HALB) announces the commencement of its patented extra-corporeal process experimentation using lasers to eradicate... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications May 10, 2021 JACKSON CENTER, PA / ACCESSWIRE / May 10, 2021 / Halberd Corporation (OTC PINK:HALB) was recently discussed in Penny Stocks News and Wall Street Trader publications as a BREAKOUT stock to watch with a... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease May 04, 2021 JACKSON CENTER, PA / ACCESSWIRE / May 4, 2021 / Halberd Corporation (OTC PINK:HALB) announces the appointment of Dr. Mitchell S. Felder, previously a consultant to Halberd Corporation, to the position... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser April 26, 2021 JACKSON CENTER, PA / ACCESSWIRE / April 26, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Treating... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations April 21, 2021 JACKSON CENTER, PA / ACCESSWIRE / April 21, 2021 / Halberd Corporation's (OTC PINK:HALB) two patent-pending monoclonal antibodies have demonstrated strong affinity and neutralizing capabilities against... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward with the Addition of Youngstown State University (YSU) and Dr. William G. Sturrus April 19, 2021 Brings Critical Radio Frequency Wave Expertise to Company's Effort JACKSON CENTER, PA / ACCESSWIRE / April 19, 2021 / Halberd Corporation (OTC PINK:HALB) is pleased to announce Youngstown State... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment April 12, 2021 JACKSON CENTER, PA / ACCESSWIRE / April 12, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Covid-19... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.